Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intralesional Antimony for Bolivian Cutaneous Leishmaniasis

This study has been completed.
Sponsor:
Collaborators:
The Alfred Berman Foundation for Medical Research
Universidad Mayor de San Simón
Hospital Dermatológico de Jorochito
Proyecto OSCAR
Information provided by (Responsible Party):
Fundacion Nacional de Dermatologia
ClinicalTrials.gov Identifier:
NCT01300975
First received: February 17, 2011
Last updated: July 3, 2012
Last verified: July 2012